Lifecore Biomedical Inc. Cash Flow Conversion Efficiency
Lifecore Biomedical Inc. cash flow conversion efficiency. Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has a cash flow conversion efficiency ratio of -0.136x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.19 Million) by net assets ($16.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Lifecore Biomedical Inc. market cap and net worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Lifecore Biomedical Inc. (1996–2026)
Cash flow conversion efficiency of Lifecore Biomedical Inc. from 1996 to 2026. This chart illustrates how Lifecore Biomedical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View LFCR live share price for real-time trading data and today's change.
Lifecore Biomedical Inc. Cash Flow Conversion Ratio Explained
Lifecore Biomedical Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Lifecore Biomedical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lifecore Biomedical Inc. ranked by their cash flow conversion efficiency. Review LFCR free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Powerwell Holdings Bhd
KLSE:0217
|
0.106x |
|
POLARIS RENEWABLE ENERGY
F:N4T
|
N/A |
|
Map Boga Adiperkasa Tbk PT
JK:MAPB
|
0.094x |
|
Chiang Mai Ram Medical Business Public Company Limited
BK:CMR
|
0.009x |
|
Westwood Holdings Group Inc
NYSE:WHG
|
-0.020x |
|
Surya Fajar Capital Tbk PT
JK:SFAN
|
0.039x |
|
Thai Nakarin Hospital Public Company Limited
BK:TNH
|
0.022x |
|
Texmaco Infrastructure & Holdings Limited
NSE:TEXINFRA
|
0.139x |
Annual Cash Flow Conversion Efficiency for Lifecore Biomedical Inc. (1996–2026)
The table below shows the annual cash flow conversion efficiency of Lifecore Biomedical Inc. from 1996 to 2026. Also see LFCR total asset value for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-05-31 | $-14.20 Million | $12.57 Million | -0.885x | -473.82% |
| 2025-05-31 | $1.34 Million | $-206.00K | -0.154x | -778.86% |
| 2024-05-31 | $11.31 Million | $257.00K | 0.023x | +108.83% |
| 2023-05-31 | $87.82 Million | $-22.59 Million | -0.257x | -13.81% |
| 2022-05-31 | $107.94 Million | $-24.40 Million | -0.226x | -378.28% |
| 2021-05-31 | $202.78 Million | $16.47 Million | 0.081x | +210.12% |
| 2020-05-31 | $231.04 Million | $-17.04 Million | -0.074x | -224.38% |
| 2019-05-31 | $270.14 Million | $16.02 Million | 0.059x | -24.28% |
| 2018-05-31 | $252.56 Million | $19.78 Million | 0.078x | -39.08% |
| 2017-05-31 | $228.15 Million | $29.33 Million | 0.129x | +25.30% |
| 2016-05-31 | $212.35 Million | $21.78 Million | 0.103x | -13.67% |
| 2015-05-31 | $220.11 Million | $26.16 Million | 0.119x | +15.62% |
| 2014-05-31 | $204.76 Million | $21.05 Million | 0.103x | -12.66% |
| 2013-05-31 | $180.41 Million | $21.23 Million | 0.118x | -19.60% |
| 2012-05-31 | $151.56 Million | $22.18 Million | 0.146x | +39.31% |
| 2011-05-31 | $137.73 Million | $14.47 Million | 0.105x | +85.99% |
| 2010-05-31 | $132.47 Million | $7.48 Million | 0.056x | -23.85% |
| 2009-05-31 | $127.20 Million | $9.44 Million | 0.074x | -50.88% |
| 2008-05-31 | $116.02 Million | $17.52 Million | 0.151x | +920.78% |
| 2007-05-31 | $112.07 Million | $-2.06 Million | -0.018x | -114.70% |
| 2006-05-31 | $86.82 Million | $10.87 Million | 0.125x | -29.48% |
| 2005-05-31 | $73.53 Million | $13.05 Million | 0.177x | +41.16% |
| 2004-05-31 | $63.10 Million | $7.93 Million | 0.126x | +7262.63% |
| 2002-05-31 | $57.54 Million | $-101.00K | -0.002x | +98.82% |
| 2001-05-31 | $50.87 Million | $-7.57 Million | -0.149x | -269.33% |
| 2000-05-31 | $57.00 Million | $5.01 Million | 0.088x | +177.61% |
| 1999-05-31 | $31.80 Million | $-3.60 Million | -0.113x | -12.21% |
| 1998-05-31 | $33.70 Million | $-3.40 Million | -0.101x | +34.70% |
| 1997-05-31 | $35.60 Million | $-5.50 Million | -0.154x | -57.07% |
| 1996-05-31 | $36.60 Million | $-3.60 Million | -0.098x | -- |
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device … Read more